Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Analyst Ratings

MREO's stock price has decreased by -85.63% in the past year and price targets may not have had time to catch up.

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $3	Buy	Maintains	$3	+971.05%	Sep 18, 2026
Priyanka Grover J.P. Morgan	J.P. Morgan	Sell Reiterates n/a	Sell	Reiterates	n/a	n/a	Sep 15, 2026
Kate Dellorusso LifeSci Capital	LifeSci Capital	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Aug 15, 2026
Gil Blum Needham	Needham	Buy Maintains $3	Buy	Maintains	$3	+971.05%	Aug 11, 2026

Data Source: TipRanks Last updated: Sep 18, 2026

Analyst data is provided by TipRanks. Ratings are updated within minutes to hours of analysts publishing new actions.

Update frequency:

Daily

Last checked:

Oct 30, 2026

Data Sources Report a data error